Categories: Journo Jobs

BioPharm Insight seeks investigative reporter

Come join our team at BioPharm Insight. Our New York newsroom is seeking a highly motivated reporter to join our dynamic investigative publication. The investigative Healthcare Reporter will focus on uncovering scoops and producing market moving pieces in advance of company announcements.

This challenging position will include covering all aspects of drug development, approval and marketing.

The successful candidate will keep a close eye on various aspects of the pharmaceutical and biotech sector, including R&D, licensing opportunities, M&A, regulatory issues, reimbursement, litigation and general industry trends.

QUALIFICATIONS

– Strong knowledge of the drug development process and healthcare industry

-Ability to perform to a high standard under pressure and meet strict deadlines

– Previous experience on a daily or weekly publication preferred

– Excellent communication, reporting, interviewing and writing skills

– Team-oriented approach with ability to work in an interactive news room environment

-Ability to collaborate on stories with our team of London reporters

– Bachelor’s degree (preferably in Journalism and/or science-related field)

ATTRIBUTES

– You are comfortable conducting interviews with high-level regulatory officials, physicians, consultants and industry executives.

-Your goal is to provide forward-looking reports on R&D activities.

-The pharmaceutical and biotech sectors, drug development regulations and reimbursement are topics you find fascinating.

– Uncovering new industry trends, facts and breaking news daily – your prime motivation.

– You keep on top of new developments.

– Health care and investor conferences are a place where you eagerly network and thrive.

BENEFITS AND COMPENSATION

The compensation package is competitive, with a benefits package of health, vision and dental insurance as well as a 401(k) plan. We offer a generous 20 days of paid time off (plus holidays as per the New York Stock Exchange).

ABOUT US

BioPharm Insight publishes real-time news and data on the most price-sensitive issues in the global healthcare market. Our diverse team consistently provides an exceptional product and level of analysis to a readership comprising: top-tier investment banks, hedge funds and corporate subscribers in the healthcare sector. BioPharm Insight is a part of Infinata, a division of the MergerMarket Group.

Interested candidates should send a cover letter, resume and two writing samples to Hanan Kamal, North American Editor, at hkamal@biopharminsight.com.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.

Recent Posts

SpaceNews hires Gruss as chief content and strategy officer

Mike Gruss, the former editor in chief of Defense News, has been hired as chief…

6 mins ago

Marfil among the WSJ layoffs in DC

Jude Marfil, newsroom operations manager for The Wall Street Journal in its Washington office, was…

16 hours ago

Greene departing Cointelegraph

Tristan Greene, deputy U.S. news editor at cryptocurrency news site CoinTelegraph, is leaving next month…

16 hours ago

Dynamo hires former Business Insider executive editor Harrington

Former Business Insider executive editor Rebecca Harrington has been hired by Dynamo to be its…

3 days ago

Bloomberg TV hires Kerubo as desk producer

Bloomberg Television has hired Brenda Kerubo as a desk producer in London. She will be covering Europe's…

3 days ago

Jittery CNBC staff reassured by new boss

In a meeting at CNBC headquarters Thursday afternoon, incoming boss Mark Lazarus presented a bullish…

3 days ago